These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32124215)

  • 1. Effects of Laparoscopic Sleeve Gastrectomy on Non-Alcoholic Steatohepatitis and Liver Fibrosis in Japanese Patients with Severe Obesity.
    Nikai H; Ishida K; Umemura A; Baba S; Nitta H; Sugai T; Sasaki A
    Obes Surg; 2020 Jul; 30(7):2579-2587. PubMed ID: 32124215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of laparoscopic sleeve gastrectomy on fibrosis stage in patients with child-A NASH-related cirrhosis.
    Salman MA; Mikhail HMS; Nafea MA; Sultan AAEA; Elshafey HE; Tourky M; Awad A; Abouelregal TE; Ahmed RA; Ashoush O; AbdelAal AA; Shaaban HE; Atallah M; Yousef M; Salman AA
    Surg Endosc; 2021 Mar; 35(3):1269-1277. PubMed ID: 32152677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study).
    Lavín-Alconero L; Fernández-Lanas T; Iruzubieta-Coz P; Arias-Loste MT; Rodriguez-Duque JC; Rivas C; Cagigal ML; Montalbán C; Useros AL; Álvarez-Cancelo A; García-Saiz M; Crespo-García J
    Trials; 2021 Oct; 22(1):756. PubMed ID: 34717726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation.
    Cabré N; Luciano-Mateo F; Fernández-Arroyo S; Baiges-Gayà G; Hernández-Aguilera A; Fibla M; Fernández-Julià R; París M; Sabench F; Castillo DD; Menéndez JA; Camps J; Joven J
    Metabolism; 2019 Oct; 99():81-89. PubMed ID: 31279739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic Sleeve Gastrectomy on the Horizon as a Promising Treatment Modality for NAFLD.
    Salman MA; Salman AA; Abdelsalam A; Atallah M; Shaaban HE; El-Mikkawy A; Omar MG; Elshenoufy M
    Obes Surg; 2020 Jan; 30(1):87-95. PubMed ID: 31372873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Benefit of Sleeve Gastrectomy in Obese Adolescents on Nonalcoholic Steatohepatitis and Hepatic Fibrosis.
    Manco M; Mosca A; De Peppo F; Caccamo R; Cutrera R; Giordano U; De Stefanis C; Alisi A; Baumann U; Silecchia G; Nobili V
    J Pediatr; 2017 Jan; 180():31-37.e2. PubMed ID: 27697327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy.
    Bettini S; Bordigato E; Milan G; Dal Pra' C; Favaretto F; Belligoli A; Sanna M; Serra R; Foletto M; Prevedello L; Busetto L; Fassina G; Vettor R; Fabris R
    Obes Facts; 2019; 12(3):291-306. PubMed ID: 31104052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of sleeve gastrectomy for non-alcoholic steatohepatitis estimated by paired liver biopsy in morbidly obese Japanese patients.
    Murakami E; Nakahara T; Hiramatsu A; Morio K; Fujino H; Yamauchi M; Kawaoka T; Tsuge M; Imamura M; Aikata H; Fudeyasu K; Nakashima Y; Iwaki D; Jodai D; Ohigashi T; Nishimura Y; Minamoto Y; Nagao A; Yoneda M; Saeki Y; Tanabe K; Ohdan H; Chayama K
    Medicine (Baltimore); 2021 Jul; 100(26):e26436. PubMed ID: 34190166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic Steatohepatitis Modifies Serum Iron-Related Variables in Patients with Morbid Obesity.
    Hernández-Aguilera A; Casacuberta N; Castañé H; Fibla M; Fernández-Arroyo S; Fort-Gallifa I; París M; Sabench F; Del Castillo D; Baiges-Gaya G; Rodríguez-Tomàs E; Sans T; Camps J; Joven J
    Biol Trace Elem Res; 2021 Dec; 199(12):4555-4563. PubMed ID: 33559024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of weight loss induced by laparoscopic sleeve gastrectomy on liver histology and serum adipokine levels.
    Salman AA; Sultan AAEA; Abdallah A; Abdelsalam A; Mikhail HMS; Tourky M; Omar MG; Youssef A; Ahmed RA; Elkassar H; Seif El Nasr SM; Shaaban HE; Atallah M; GabAllah GMK; Salman MA
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1769-1773. PubMed ID: 32153044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy.
    Ramos-Molina B; Castellano-Castillo D; Pastor O; Ocaña-Wilhelmi L; Fernández-García D; Romero-Gómez M; Cardona F; Tinahones FJ
    Obes Surg; 2019 Mar; 29(3):983-989. PubMed ID: 30488259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Laparoscopic Sleeve Gastrectomy and Gastric Bypass Surgery on Non-Alcoholic Steatohepatitis in Iranian Patients with Obesity.
    Elyasinia F; Jalali SM; Zarini S; Sadeghian E; Sorush A; Pirouz A
    Middle East J Dig Dis; 2021 Jul; 13(3):200-207. PubMed ID: 36606220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
    Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
    Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of laparoscopic sleeve gastrectomy on nonalcoholic fatty liver disease and TGF-β signaling pathway.
    Kumagai H; Sasaki A; Umemura A; Kakisaka K; Iwaya T; S Nishizuka S
    Endocr J; 2024 Feb; 71(2):139-152. PubMed ID: 38171883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic sleeve gastrectomy alters
    Cabré N; Gil M; Amigó N; Luciano-Mateo F; Baiges-Gaya G; Fernández-Arroyo S; Rodríguez-Tomàs E; Hernández-Aguilera A; Castañé H; París M; Sabench F; Del Castillo D; Camps J; Joven J
    Sci Rep; 2021 Jan; 11(1):1343. PubMed ID: 33446705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the changes in hepatokine levels and metabolic effects after laparoscopic sleeve gastrectomy in severely obese patients.
    Umemura A; Sasaki A; Takamura T; Takayama H; Takeshita Y; Toya Y; Kakisaka K; Hasegawa Y; Ishigaki Y
    Surg Today; 2024 Jun; 54(6):581-590. PubMed ID: 37957316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
    Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K
    J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Sleeve Gastrectomy with Duodenal-Jejunal Bypass for the Treatment of Obese Severe Diabetes Patients in Japan: a Retrospective Multicenter Study.
    Naitoh T; Kasama K; Seki Y; Ohta M; Oshiro T; Sasaki A; Miyazaki Y; Yamaguchi T; Hayashi H; Imoto H; Tanaka N; Unno M
    Obes Surg; 2018 Feb; 28(2):497-505. PubMed ID: 28795271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.
    Lassailly G; Caiazzo R; Ntandja-Wandji LC; Gnemmi V; Baud G; Verkindt H; Ningarhari M; Louvet A; Leteurtre E; Raverdy V; Dharancy S; Pattou F; Mathurin P
    Gastroenterology; 2020 Oct; 159(4):1290-1301.e5. PubMed ID: 32553765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.